Optic nerve head perfusion changes in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab or photocoagulation: a randomized controlled trial

BACKGROUND: Proliferative diabetic retinopathy (PDR) is a serious sight-threatening disease, and half of the patients with high-risk PDR can develop legal blindness within 5 years, if left untreated. This study was aimed at comparing panretinal photocoagulation (PRP) and intravitreal ranibizumab inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Helmy, Ahmed Magdy Raffat, Rashad, Mohammad Ahmad, Gharieb, Hesham Mohamed, Gomaa, Wael Adel, Zaki, Rania Gamal Eldin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Virtual Ophthalmic Research Center 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460245/
https://www.ncbi.nlm.nih.gov/pubmed/37641606
http://dx.doi.org/10.51329/mehdiophthal1459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460245/
https://www.ncbi.nlm.nih.gov/pubmed/37641606
http://dx.doi.org/10.51329/mehdiophthal1459

Ejemplares similares